Keurig Dr Pepper to Sell Chobani Stake, Pennsylvania Campus for $925 Million
Keurig Dr Pepper is selling its minority stake in Chobani back to the yogurt maker ahead of the beverage maker's planned split into two public companies.
KDP - Keurig Dr Pepper Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$37.75
DETAILS
HIGH:
$42.00
LOW:
$30.00
MEDIAN:
$38.00
CONSENSUS:
$37.75
UPSIDE:
15.83%
Stock News
Keurig Dr Pepper to sell back Chobani stake for $925 million
Keurig Dr Pepper said on Tuesday it would sell its investment in Chobani back to the yogurt maker for $925 million, as the beverage company reshapes its business following its acquisition of JDE Peet's.
Keurig Dr Pepper Advances Strategic Priorities Through Enhanced Partnership with Chobani
Selling minority investment in Chobani and Pennsylvania facility for $925 million in pre-tax proceeds Proceeds to support Keurig Dr Pepper's deleveraging goals Updating and expanding long-term commercial relationship with Chobani BURLINGTON, Mass. and FRISCO, Texas, Sept.
Keurig Dr Pepper Director Aaron Alt Buys 7,862 Shares for $250,000 -- Should Investors Buy Too?
Director Aaron E. Alt purchased 7,862 shares on Aug. 25, 2026, for an estimated total value of ~$250,000.
Coffee Prices Are High. Why Ground Coffee Is Holding Up Better Than K-Cups.
Raw coffee costs have eased from last year's highs, but remain historically elevated.
Keurig Dr Pepper to Participate in Barclays Global Consumer Staples Conference
FRISCO, Texas and BURLINGTON, Mass., Aug. 27, 2026 /PRNewswire/ -- Keurig Dr Pepper Inc. (NASDAQ: KDP) today announced that Tim Cofer, Chief Executive Officer, and Anthony DiSilvestro, Chief Financial Officer, will participate in a fireside chat at the Barclays Global Consumer Staples Conference on September 10, 2026 at 9:00 AM ET.
30,438 Shares in Keurig Dr Pepper, Inc $KDP Acquired by Callan Family Office LLC
Callan Family Office LLC acquired a new stake in Keurig Dr Pepper, Inc (NASDAQ: KDP) during the second quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 30,438 shares of the company's stock, valued at approximately $996,000. Several other large investors have also added to or reduced their
Can Keurig Dr Pepper's Energy Growth Offset Coffee Market Softness?
KDP's fast-rising energy portfolio is nearing double-digit share as U.S. Coffee battles weaker sales, shipments and higher costs.
Aurora Investment Counsel Takes $1 Million Position in Keurig Dr Pepper, Inc $KDP
Aurora Investment Counsel purchased a new stake in Keurig Dr Pepper, Inc (NASDAQ: KDP) in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 30,602 shares of the company's stock, valued at approximately $1,002,000. Several other institutional investors also recently
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
Each week, Benzinga's Stock Whisper Index uses a combination of proprietary data and pattern recognition to showcase five stocks that are just under the surface and deserve attention.
Can JDE Peet's Become an Even Bigger Growth Driver for KDP?
Keurig Dr Pepper sees JDE Peet's integration, revenue synergies and $400M in cost savings boosting coffee growth ahead of the 2027 separation.
Here Are Thursday’s Top Wall Street Analyst Research Calls: Abbott Labs, AbbVie, Akamai Technologies, Five Below, Keurig Dr. Pepper, Salesforce, Stryker, StubHub, and More
Wall Street analysts made bold moves Thursday, slashing targets on some names while dramatically upgrading others, and the gap between winners and losers tells a story about where smart money is quietly repositioning ahead of the next market move.
Keurig Dr Pepper Announces Appointment of New Director to its Board
FRISCO, Texas and BURLINGTON, Mass., Aug. 12, 2026 /PRNewswire/ -- Keurig Dr Pepper Inc. (NASDAQ: KDP) announced today that Aaron Alt has been appointed a director of the Company's Board of Directors, effective August 14, 2026.
KDP vs. MNST: Which Stock Should Value Investors Buy Now?
Investors looking for stocks in the Beverages - Soft drinks sector might want to consider either Keurig Dr Pepper, Inc (KDP) or Monster Beverage (MNST). But which of these two stocks presents investors with the better value opportunity right now?
Here's Why Keurig Dr Pepper, Inc (KDP) is a Strong Value Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Oakmark Concentrated Strategy Q2 2026 Performance Review
The portfolio's return was 9.21% (net) for the reporting period. Centene, ICON and Keurig Dr Pepper were the contributors during the quarter. Intercontinental Exchange, Salesforce and ConocoPhillips were the detractors during the quarter.
PepsiCo's Foods Segment: Sustainable Recovery or Temporary Relief?
PEP's U.S. foods business is regaining volume growth as affordability moves and portfolio changes take hold, but staying power remains the key test.
7UP Puts Lime in the Spotlight With Its Biggest Brand Evolution in More Than 15 Years
The best-tasting 7UP ever combines the lime-forward profile consumers preferred most with a refreshed identity that challenges convention in the lemon-lime category FRISCO, Texas, Aug. 10, 2026 /PRNewswire/ -- 7UP®, part of the Keurig Dr Pepper (NASDAQ: KDP) portfolio of brands, is redefining the $5 billion lemon-lime category1 with its first evolution in over 15 years, with a lime-led reformulation at the center. The debut of 7UP Lime Lemon marks the category's first lime-led formula designed to strengthen the brand's distinctiveness and appeal with a new generation of drinkers.
The Energy Drink Buyout Prize Beverage Giants Are Circling
Celsius Holdings (NASDAQ:CELH | CELH Price Prediction) has become one of the most talked-about consolidation candidates in beverages.
Keurig Dr Pepper Q2 Earnings Call Highlights
Keurig Dr Pepper NASDAQ: KDP reported second-quarter results that exceeded its expectations, supported by strong growth in U.S. Refreshment Beverages and an incremental contribution from its acquisition of JDE Peet's, which closed April 1.
Price Targets
Morgan Stanley Resumes Keurig Dr Pepper (KDP) at Overweight
$38.00
(was $31.06)
Dara Mohsenian
·
Morgan Stanley
Keurig Dr Pepper upgraded to Buy from Hold at HSBC
$40.00
(was $29.56)
HSBC
Keurig Dr Pepper price target raised to $38 from $36 at Barclays
$38.00
(was $30.01)
Barclays
RBC Capital 'Expecting Another Solid Quarter' From Keurig Dr Pepper (KDP)
$42.00
(was $30.88)
Nik Modi
·
RBC Capital
Keurig Dr Pepper price target raised to $38 from $34 at UBS
$38.00
(was $31.05)
Peter Grom
·
UBS
Keurig Dr Pepper (KDP) PT Raised to $39 at Bernstein SocGen GroupMember Login
$39.00
(was $31.23)
Bernstein
Keurig Dr Pepper added to Q3 Tactical Ideas List at Wells Fargo
$37.00
(was $32.73)
Wells Fargo
Bernstein starts Keurig Dr Pepper at Outperform with $38 target
$38.00
(was $31.23)
Bernstein
Keurig Dr Pepper price target raised to $34 from $32 at UBS
$34.00
(was $28.85)
UBS
Keurig Dr Pepper price target raised to $30 from $28 at Evercore ISI
$30.00
(was $28.76)
Evercore ISI
Keurig Dr Pepper price target lowered to $28 from $32 at Barclays
$28.00
(was $25.93)
Barclays
Keurig Dr Pepper (KDP) PT Raised to $36 at UBS: 'Valuation Still Attractive'
$36.00
(was $30.49)
Peter Grom
·
UBS
Keurig Dr Pepper downgraded to Hold from Buy at Jefferies
$32.00
(was $28.59)
Kaumil Gajrawala
·
Jefferies
Keurig Dr Pepper price target raised to $38 from $35 at Piper Sandler
$38.00
(was $29.50)
Michael Lavery
·
Piper Sandler
Keurig Dr Pepper downgraded to Hold from Buy at Deutsche Bank
$32.00
(was $29.50)
Deutsche Bank
UBS Reiterates Buy Rating on Keurig Dr Pepper (KDP)
$35.00
(was $28.69)
Peter Grom
·
UBS
Keurig Dr Pepper price target raised to $30 from $26 at Barclays
$30.00
(was $28.64)
Lauren Lieberman
·
Barclays
Keurig Dr Pepper price target raised to $35 from $33 at Wells Fargo
$35.00
(was $28.68)
Wells Fargo
Keurig Dr Pepper downgraded to Underperform from Neutral at BNP Paribas Exane
$24.00
(was $27.11)
Kevin Grundy
·
BNP Paribas
Keurig Dr Pepper downgraded to Hold from Buy at HSBC
$30.00
(was $30.48)
Sorabh Daga
·
HSBC